TMCnet News
NPL Launches Metrology for Medical Physics Centre to Accelerate Therapies for Cancer, Dementia and Heart DiseaseLONDON, February 23, 2018 /PRNewswire/ -- In response to rising healthcare challenges in the UK, the NPL, the UK's National Measurement Institute (NMI), has today announced the launch of MEMPHYS, to address the critical need for early diagnosis and treatment of conditions such as cancer, dementia and heart disease. In its Industrial Strategy Green Paper and Accelerated Access Review, the UK government has recognised the need to speed up the adoption of innovative new diagnostic tools, treatments and medical technologies, to make the UK home to world-class healthcare[1],[2]. MEMPHYS will help to meet this need, functioning as an international centre for excellence, fostering interdisciplinary and inter-sector research to inspire cutting-edge innovations. MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies. The Centre will also act as a launch platform, providing a range of services including, consultancy and advice, commissioning and validation methodologies and quality assurance protocols and training. Advanced technologies currently undergoing development in the UK, which will benefit from the Centre's support include:
Rebecca Nutbrown, Head of Metrology for Medical physics at NPL: "We know that, to enable the rapid and widespread adoption of new innovations into clinical practice, we must first ensure that their performance, safety and effectiveness have been thoroughly measured and optimised. Through MEMPHYS, we will work with our partners to tackle some of the world's biggest health challenges. From supporting the diagnosis and treatment of diseases, to drug efficacy evaluation, we will undertake research and share our expertise with government, business and the health service, to help enhance healthcare and improve quality of life for patients in the UK, and across the world." References
Contact information: Alex Cloney, AprilSix Proof on behalf of NPL, [email protected], +44 (0)20 3141 2970 |